Spectroscopic metabolic abnormalities in mTLE with and without MRI evidence for mesial temporal sclerosis using hippocampal short-TE MRSI

Epilepsia

Volumn 44, Issue 7, 2003, Pages 977-980

  Mueller, Susanne G ^a,c   Laxer, Kenneth D ^b   Suhy, Joyce ^a   Lopez, Ria C ^a   Flenniken, Derek L ^a   Weiner, Michael W ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Epilepsy; Myoinositol; Short echo time; Spectroscopy

Indexed keywords

INOSITOL; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPILEPTOGENESIS; HIPPOCAMPUS; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SPECTROSCOPY; TEMPORAL LOBE EPILEPSY;

ADULT; ASPARTIC ACID; CHOLINE; CREATINE; DIAGNOSIS, DIFFERENTIAL; DOMINANCE, CEREBRAL; ENERGY METABOLISM; EPILEPSY, TEMPORAL LOBE; FEMALE; HIPPOCAMPUS; HUMANS; INOSITOL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; SCLEROSIS;

EID: 0038491567     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2003.50202.x     Document Type: Article

References (15)

1. Tanabe JL, Amend D, Schuff N, et al. Tissue segmentation of the brain in Alzheimer disease. AJNR Am J Neuroradiol 1997;18:115-23.
2. Vermathen P, Laxer KD, Matson GB, et al. Hippocampal structures: anteroposterior N-acetylaspartate differences in patients with epilepsy and control subjects as shown with proton MR spectroscopic imaging. Radiology 2000;214:403-10.
3. Ende GR, Laxer KD, Knowlton RC, et al. Temporal lobe epilepsy: bilateral hippocampal metabolite changes revealed at proton MR spectroscopic imaging. Radiology 1997;202:809-17.
4. 1H spectroscopic imaging and hippocampal volumetry in the lateralization of mesial temporal lobe epilepsy. Neurology 1998;51:66-71.
5. 1H-magnetic resonance spectroscopic imaging (MRSI) of the temporal lobes. Neuroimage 2001;14:501-9.
6. Simister RJ, Woermann FG, McLean MA, et al. A short-echo-time proton magnetic resonance spectroscopic imaging study of temporal lobe epilepsy. Epilepsia 2002;43:1021-31.
7. 1H-magnetic resonance spectroscopy in magnetic resonance imaging: negative temporal lobe epilepsy: different biochemical profile compared with hippocampal sclerosis. Ann Neurol 1999;45:369-76.
8. Wellard RM, Briellmann RS, Syngeniotis A, et al. Frontal lobe myoinositol abnormalities in temporal lobe epilepsy. Proc Int Soc Mag Reson Med 2002;10:415(abstract).
9. Wolfson M, Bersudsky Y, Hertz E, et al. A model of inositol compartmentation in astrocytes based upon efflux kinetics and slow inositol depletion after uptake inhibition. Neurochem Res 2000;25:977-82.
10. +/myo-inositol cotransporter mRNA in rat brain. Mol Brain Res 1999;70:179-86.
11. Carmant L, Liu Z, Werner SJ, et al. Effect of kainic acid induced status epilepticus on inositol-triphosphate and seizure induced brain damage in mature and immature animals. Dev Brain Res 1995;89:67-72.
12. Hirvonen MR, Paljarvi L, Savolainen KM. Sustained effects of pilocarpine-induced convulsions on brain inositol and inositol monophosphate levels and brain morphology in young and old male rats. Toxicol Appl Pharmacol 1993;122:290-9.
13. Van Calker D, Belmaker RH. The affinity inositol transport system: implication for the pathophysiology and treatment of bipolar disorders. Bipolar Disord 2000;2:102-7.
14. Vadnal R, Parthasarathy R. Myo-inositol monophosphatase: diverse effects of lithium, carbamazepine and valproate. Neuropsychopharmacology 1995;12:277-85.
15. Savic I, Thomas AE, Ke Y, et al. In vivo measurements of glutamine + glutamate (Glnx) and N-acetyl aspartate (NAA) levels in human partial epilepsy. Acta Neurol Scand 2000;102:179-88.